Summary
Virazole (ribavirin) inhibits the RNA synthesis of an influenza A virus (fowl plague). Neither virion RNA nor complementary RNA are produced. Although the effect of virazole can be counteracted by guanosine the inhibitor does not interfere with the uptake or incorporation of labelled guanosine into chick embryo cells, nor does replacement of glucose by mannose amplify the effect of virazole. Thus virazole seems not to act via an interference with the GTP pool. Synthesis of Semliki Forest virus RNA is not affected by virazole.
This is a preview of subscription content, log in via an institution to check access.
References
Davenport, F. M., Rott, R., Schäfer, W.: Physical and biochemical properties of influenza virus components obtained after ether treatment. J. exp. Med.112, 765–782 (1960).
Drzeniek, R., Seto, J. T., Rott, R.: Characterization of neuraminidase from myxoviruses. Biochim. biophys. Acta (Amst.)128, 547–558 (1966).
Hammer, G., Schwarz, R. T., Scholtissek, C.: Effect of infection with enveloped viruses on nucleotide metabolism. Virology (in press).
Oxford, J. S.: Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (Ribavirin). J. gen. Virol.28, 409–414 (1975).
Scholtissek, C.: Synthesisin vitro of RNA complementary to parental viral RNA by RNA polymerase induced by influenza virus. Biochim. biophys. Acta (Amst.)179, 389–397 (1969).
Scholtissek, C.: Detection of an unstable RNA in chick fibroblasts after reduction of the UTP pool by glucosamine. Europ. J. Biochem.24, 358–365 (1971).
Scholtissek, C., Rott, R.: Synthesisin vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Virology40, 989–996 (1970).
Scholtissek, C., Rott, R., Klenk, H.-D.: Two different mechanisms of the inhibition of the multiplication of enveloped viruses by glucosamine. Virology63, 191 to 200 (1975).
Sidwell, R. W., Huffman, J. H., Khare, G. P., Allen, L. B., Witkowski, J. T., Robins, R. K.: Broad spectrum antiviral activity of virazole, 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science (New York)177, 705–706 (1972).
Streeter, D. G., Witkowski, J. T., Khare, G. P., Sidwell, R. W., Bauer, R. J., Robins, R. K., Simon, L. N.: Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad spectrum antiviral agent. Proc. Natl. Acad. Sci. U.S.A.70, 1174–1178 (1973).
Suganuma, T., Ishida, N.: An evaluation of a new antiviral agent “virazole” against influenza virus infections. Tohoku J. exp. Med.10, 405–406 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scholtissek, C. Inhibition of influenza RNA synthesis by virazole (ribavirin). Archives of Virology 50, 349–352 (1976). https://doi.org/10.1007/BF01317961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317961